OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL)

Q: What does CUSIP 67576A100 represent in this 13F holders report?

CUSIP 67576A100 is the security identifier for OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in Q3 2017?

71 institutional investors reported OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share for Q3 2017. Use the holders table for investor-level position and value details.

CUSIP: 67576A100

Q3 2017 13F Holders as of 30 Sep 2017

Security type / class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 218,782,791
Total 13F shares: 15,581,267
Share change: +87,205
Total reported value: $96,508,272
Put/Call ratio: 119%
Reported price per share: $6.18
Number of holders: 71
Value change: -$1,101,751
Number of buys: 33
Number of sells: 24

Security key

67576A100

Report period

Q3 2017

Institutions

Top holders

OCUL full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2017 Previous quarter: Q2 2017 OCULAR THERAPEUTIX, INC SEC filings OCULAR THERAPEUTIX, INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 67576A100

Newer quarter: Q4 2017 Previous quarter: Q2 2017

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Versant Venture Managemen...

13D/G signal

—

Evidence rows

Latest as of

30 Jun 2017

13F Lead comparable stake: 1% Showing 1-6 of 15 holder rows.

Rank 1 holder

Versant Venture Management, LLC

13F

Ownership: 1%
Position: $20.54M

13F

Rank 2 holder

JENNISON ASSOCIATES LLC

13F

Ownership: 0.91%
Position: $18.41M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Versant Venture Management, LLC	13F Company 13F	1%	$20,536,610 2,215,384 shares	—	30 Jun 2017
JENNISON ASSOCIATES LLC	13F Company 13F	0.91%	$18,406,000 1,985,496 shares	—	30 Jun 2017
SV Health Investors, LLC	13F Company 13F	0.73%	$14,880,000 1,605,207 shares	—	30 Jun 2017
BlackRock Finance, Inc.	13F Company 13F	0.63%	$12,794,000 1,380,100 shares	—	30 Jun 2017
FMR LLC	13F Company 13F	0.61%	$12,276,000 1,324,299 shares	—	30 Jun 2017
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	0.6%	$12,130,000 1,308,563 shares	—	30 Jun 2017

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

15,581,267

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders

Q3 2017 holders

Holder diff

Investor	Q2 2017 Shares	Q3 2017 Shares	Share Diff	Share Chg %	Q2 2017 value	Q3 2017 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend